Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Brain tumor classification using AFM in combination with data mining techniques.

Marlene Huml1, René Silye, Gerald Zauner

  • 1School of Applied Health and Social Sciences, University of Applied Sciences Upper Austria, Garnisonstraße 21, 4020 Linz, Austria.

Biomed Research International
|September 25, 2013
PubMed
Summary

Atomic force microscopy (AFM) combined with data mining offers an objective method for grading astrocytoma tumors. This approach accurately distinguishes between low-grade and high-grade tumors, improving diagnostic reliability.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Clinical impact of real-time androgen receptor alteration monitoring on metastatic castration-resistant prostate cancer treatment in real-world settings.

International journal of cancer·2025
Same author

Clinical Implementation of a Noninvasive, Multi-Analyte Droplet Digital PCR Test to Screen for Androgen Receptor Alterations.

The Journal of molecular diagnostics : JMD·2024
Same author

Validation of a next-generation sequencing assay for the detection of EGFR mutations in cell-free circulating tumor DNA.

Experimental and molecular pathology·2021
Same author

Extension of the Thermographic Signal Reconstruction Technique for an Automated Segmentation and Depth Estimation of Subsurface Defects.

Journal of imaging·2021
Same author

Artificial neural networks and pathologists recognize basal cell carcinomas based on different histological patterns.

Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc·2020
Same author

Accuracy of grading pancreatic neuroendocrine neoplasms with Ki-67 index in fine-needle aspiration cellblock material.

Cytopathology : official journal of the British Society for Clinical Cytology·2018

Area of Science:

  • Neuro-oncology
  • Biophysics
  • Computational Pathology

Background:

  • Standard astrocytoma tumor grading relies on WHO system, facing significant interobserver variability.
  • Variability stems from complex morphology, inconsistent histopathological procedures, and pathologist experience.
  • Objective grading is crucial for accurate prognosis and treatment of astrocytoma patients.

Purpose of the Study:

  • To develop an objective methodology for astrocytoma grading using atomic force microscopy (AFM) and data mining.
  • To improve the accuracy and reduce variability in differentiating astrocytoma grades.
  • To identify reliable morphological markers for computer-assisted tumor classification.

Main Methods:

  • Histopathological samples were analyzed using atomic force microscopy (AFM) and light microscopy.

Related Experiment Videos

  • AFM images were compared with light microscopy images to identify morphological differences.
  • Genetic programming was employed for feature analysis and model creation to classify tumor grades.
  • Main Results:

    • Progressive cavity formation due to cell necrosis was identified as a key morphological marker.
    • A classification model achieved 94.74% accuracy in distinguishing grade II from grade IV astrocytoma tumors.
    • The study demonstrates the potential of AFM in objective astrocytoma diagnosis.

    Conclusions:

    • AFM-based image analysis combined with data mining offers a more objective standard for astrocytoma grading.
    • Accurate identification of grade II tumors can prevent unnecessary treatments and enable timely adjuvant therapies.
    • This methodology holds promise for improving patient outcomes by enabling unambiguous diagnosis and risk stratification.